| Primary |
| Drug Use For Unknown Indication |
26.7% |
| Hypertension |
13.3% |
| Metastatic Renal Cell Carcinoma |
13.3% |
| Osteoarthritis |
13.3% |
| Anticoagulant Therapy |
6.7% |
| Coronary Artery Disease |
6.7% |
| Pain Management |
6.7% |
| Product Used For Unknown Indication |
6.7% |
| Prophylaxis |
6.7% |
|
| Pigmentation Disorder |
16.7% |
| Vomiting |
16.7% |
| Cerebrovascular Accident |
8.3% |
| Epistaxis |
8.3% |
| Faeces Discoloured |
8.3% |
| Ileitis |
8.3% |
| Rectal Haemorrhage |
8.3% |
| Retinal Haemorrhage |
8.3% |
| Skin Laceration |
8.3% |
| Tumour Haemorrhage |
8.3% |
|
| Secondary |
| Product Used For Unknown Indication |
22.8% |
| Drug Use For Unknown Indication |
14.2% |
| Acute Coronary Syndrome |
9.1% |
| Atrial Fibrillation |
7.1% |
| Aggression |
4.6% |
| Bipolar Disorder |
4.6% |
| Coronary Artery Disease |
4.1% |
| Medical Diet |
4.1% |
| Cardiac Disorder |
3.0% |
| Diabetes Mellitus |
3.0% |
| Hypertension |
3.0% |
| Routine Health Maintenance |
3.0% |
| Blood Cholesterol Increased |
2.5% |
| Cerebrovascular Accident Prophylaxis |
2.5% |
| Coronary Arterial Stent Insertion |
2.0% |
| Dementia Alzheimer's Type |
2.0% |
| Hyperchlorhydria |
2.0% |
| Peritoneal Dialysis |
2.0% |
| Rosacea |
2.0% |
| Vitamin Supplementation |
2.0% |
|
| Colitis Ulcerative |
13.9% |
| Rash |
11.1% |
| Atrial Fibrillation |
8.3% |
| Iron Deficiency Anaemia |
8.3% |
| Drug Interaction |
5.6% |
| Malaise |
5.6% |
| Platelet Count Decreased |
5.6% |
| Upper Respiratory Tract Infection |
5.6% |
| Visual Midline Shift Syndrome |
5.6% |
| Blood Pressure Increased |
2.8% |
| Dizziness |
2.8% |
| Drug Hypersensitivity |
2.8% |
| Epistaxis |
2.8% |
| Hypertension |
2.8% |
| Nervousness |
2.8% |
| Oesophageal Irritation |
2.8% |
| Product Quality Issue |
2.8% |
| Renal Failure |
2.8% |
| Speech Disorder |
2.8% |
| Syncope |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.2% |
| Product Used For Unknown Indication |
17.2% |
| Hypertension |
9.5% |
| Pain |
4.8% |
| Blood Cholesterol Increased |
4.1% |
| Cardiac Disorder |
3.2% |
| Depression |
3.1% |
| Arthritis |
3.0% |
| Anxiety |
2.7% |
| Rheumatoid Arthritis |
2.4% |
| Prophylaxis |
2.4% |
| Diabetes Mellitus |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Osteoporosis |
2.2% |
| Multiple Sclerosis |
2.1% |
| Atrial Fibrillation |
1.6% |
| Chest Pain |
1.5% |
| Arthralgia |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
|
| Weight Decreased |
12.4% |
| Vomiting |
11.0% |
| Myocardial Infarction |
9.4% |
| Transient Ischaemic Attack |
7.2% |
| Urinary Tract Infection |
6.9% |
| Weight Increased |
6.3% |
| Pneumonia |
5.5% |
| Tremor |
5.0% |
| Nausea |
4.1% |
| Renal Failure Acute |
3.9% |
| Vision Blurred |
3.9% |
| White Blood Cell Count Increased |
3.3% |
| Wrong Technique In Drug Usage Process |
3.0% |
| Drug Ineffective |
2.8% |
| Pyrexia |
2.8% |
| Wheezing |
2.8% |
| Hypertension |
2.5% |
| Oedema Peripheral |
2.5% |
| Paraesthesia |
2.5% |
| Upper Respiratory Tract Infection |
2.5% |
|
| Interacting |
| Discomfort |
50.0% |
| Insomnia |
50.0% |
|
| Therapeutic Response Decreased |
100.0% |
|
